Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,882
Closed -$736K 831
2025
Q4
$736K Sell
9,882
-3,420
-26% -$250K 0.02% 554
2025
Q3
$898K Buy
13,302
+1,032
+8% +$68.5K 0.04% 276
2025
Q2
$800K Buy
12,270
+3,147
+34% +$189K 0.04% 278
2025
Q1
$532K Sell
9,123
-324
-3% -$21.5K 0.03% 344
2024
Q4
$609K Sell
9,447
-922
-9% -$72K 0.03% 333
2024
Q3
$854K Buy
10,369
+4,251
+69% +$340K 0.05% 256
2024
Q2
$505K Sell
6,118
-304
-5% -$22.8K 0.03% 347
2024
Q1
$485K Sell
6,422
-85
-1% -$6.32K 0.03% 349
2023
Q4
$492K Buy
+6,507
New +$453K 0.04% 356
2022
Q2
$235K Buy
+3,309
New +$246K 0.03% 457

Other funds holding HOLX

HighPoint Advisor Group's HOLX Position: Q1 2026 in Review

HighPoint Advisor Group sold out of Hologic (HOLX) in Q1 2026, closing a stake of 9,882 shares — an estimated $736K sold.

HighPoint Advisor Group first reported a position in HOLX in Q2 2022 and held it in 10 quarters. The position peaked at $898K in Q3 2025. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • HighPoint Advisor Group reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • HighPoint Advisor Group sold 9,882 Hologic shares in Q1 2026, an estimated $736K.
  • HighPoint Advisor Group first reported a position in Hologic in Q2 2022 and held it in 10 quarters.
  • HighPoint Advisor Group's Hologic position peaked at $898K in Q3 2025.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on HighPoint Advisor Group's 13F filing for Q1 2026, filed 14 May 2026.